2018
DOI: 10.1007/s00345-018-2355-y View full text |Buy / Rent full text
|
|

Abstract: Long recognized to confer an extremely poor prognosis, sarcomatoid dedifferentiation of renal cell carcinoma (sRCC) is a tumor phenotype that is finally beginning to be better understood on the molecular and genetic levels. With an overall incidence that ranges from 1 to 32% depending on associated RCC subtype, the survival of sarcomatoid RCC patients rarely exceeds 2 years. The main reasons for its poor outcome include its aggressive biology, its tendency to present at an advanced or metastatic stage at the t… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
14
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals